James moved to the pharmaceutical industry in 1993 after a clinical career in general medicine and anaesthetics. He held a series of global clinical and commercial roles at major pharmaceutical companies prior to founding Prism in 2001. James’s experience spans all phases of clinical research and medical affairs, leading the clinical contribution to many regulatory interactions with the EMA and FDA, as well as launching products. He has published widely across a variety of therapeutic areas and continues to work on client projects.